This content was paid for by GSK and produced in partnership with the Financial Times Commercial department
Making an impact: Science. Partnership. Scale.

Making an impact: Science. Partnership. Scale.

Uniting science, technology and talent to impact health, society and the planet
Why low-carbon inhalers could help people and the planet
Metered-dose inhalers are one of the biggest sources of greenhouse gas emissions from healthcare systems. But a new generation of inhalers could be helping to lower the sector’s carbon footprint
Read More
Why low-carbon inhalers could help people and the planet
Why tackling health inequities starts with prevention
Despite major advances in modern medicine, health disparities persist. Prevention and earlier intervention can be a powerful solution
Read More
Why tackling health inequities starts with prevention
Nature matters: why healthy people need healthy ecosystems
Cutting carbon emissions is essential for health, but it’s not the whole picture. Protecting and restoring nature is also needed to reach net zero – and to help safeguard health
Read More
Nature matters: why healthy people need healthy ecosystems
Antimicrobial resistance: the value of novel antibiotics and vaccines
With drug-resistant infections posing a growing threat, how can governments encourage the development of new vaccines and antibiotics and ensure appropriate access for patients?
Read More
Antimicrobial resistance: the value of novel antibiotics and vaccines
Why science needs clinical trial diversity
Making clinical trials more inclusive and building trust in the health system is vital if diversity goals are to achieve their aim of producing better health outcomes
Read More
Why science needs clinical trial diversity
In eradicating infectious diseases, a tough opponent: climate change
Rising global temperatures are complicating the fight against infectious diseases. What are healthcare decision-makers doing in response?
Read More
In eradicating infectious diseases, a tough opponent: climate change
Why global health partnerships can tackle infectious disease
Sharing expertise and resources is essential for the complex task of curbing the high-burden infectious diseases that affect children in lower-income countries
Read More
Why global health partnerships can tackle infectious disease
Connect with us
Stay up-to-date with the latest perspectives from GSK